Document is current
Any future updates will be listed below
-
Authors
Shin, Keewon https://orcid.org/0000-0002-5028-5716
Lee, Jung Su https://orcid.org/0000-0001-5644-0150
Lee, Ji Young https://orcid.org/0000-0002-0764-615X
Lee, Hyunsu https://orcid.org/0000-0003-3631-3028
Kim, Jeongseok https://orcid.org/0000-0003-1007-564X
Byeon, Jeong-Sik https://orcid.org/0000-0002-9793-6379
Jung, Hwoon-Yong
Kim, Do Hoon https://orcid.org/0000-0002-4250-4683
Kim, Namkug https://orcid.org/0000-0002-3438-2217
-
Funding
Funding for this research was provided by:
Korea Health Industry Development Institute (HI18C0022)
- License Information
-
More Information
Article History
Received: 5 April 2022
Revised: 21 February 2023
Accepted: 23 February 2023
First Online: 13 March 2023
Declarations
:
: This retrospective study was conducted according to the principles of the Declaration of Helsinki and was performed in accordance with current scientific guidelines. The study protocol was approved by the Institutional Review Board Committee of Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea (IRB No. 2020–0568). The requirement for informed patient consent was waived by the Institutional Review Board Committee of Asan Medical Center.
: The authors except Namkug Kim have no conflicts of interest to disclose. Namkug Kim is a stakeholder of Promedius Inc.
